Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza

被引:171
作者
Abd-Elazem, IS
Chen, HS
Bates, RB
Huang, RCC [1 ]
机构
[1] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[3] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100037, Peoples R China
[4] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA
关键词
HIV-1; inhibition; purification; HPLC; integrase; inhibitors;
D O I
10.1016/S0166-3542(02)00011-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Water soluble extracts of the herbal plant, Salvia miltiorrhiza (Danshen) exhibited potent effect against HIV-1 integrase activity in vitro and viral replication in vivo. We have developed an extensive purification scheme to isolate effective, non-toxic inhibitors against human immunodeficiency virus type 1 (HIV-1) using the 3'-processing activity of integrase as a purification guide and assay. Two water soluble compounds, M,22 and M,32, have been discovered by isolating them from S. miltiorrhiza roots in purities of >99.5%, as shown by NMR spectral analysis with yields of 0.018 and 0.038%, respectively. Structural determination revealed that M(5)22 is lithospermic acid and M(5)32 is lithospermic acid B. These two structurally related compounds are potent anti-HIV inhibitors and showed no cytotoxicity to H9 cells at high concentrations (CC100 > 297 muM for M(5)22 and > 223 muM for M(5)32). The IC50 for inhibition of 3'-processing by HIV-1 integrase was found to be 0.83 muM for M(5)22 and 0.48 muM for M(5)32. In addition, M(5)22 and M(5)32 inhibited HIV-1 integrase catalytic activities of 3'-joining to the target DNA with IC50 of 0.48 muM for M(5)22 and 0.37 muM for M(5)32. Furthermore, kinetic and mechanistic studies suggested that drug binding to HIV-1 integrase and inhibition of enzymatic activity occur at a fast rate. Both M(5)22 and M(5)32 do not prevent HIV entry in H9 cells. They also show no inhibition of reverse transcriptase activity in infected cells. The levels of intracellular strong stop and full-length viral DNA remained unchanged following drug treatment. However, both inhibitors strongly suppressed the acute HIV-1 infection of H9 cells with IC50 values of 2 and 6.9 muM for M(5)22 and M(5)32, respectively. Thus these two selective integrase inhibitors hold promise as a novel class of therapeutic drugs for AIDS based on their high potencies and absence of cytotoxicity. (c) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 106
页数:16
相关论文
共 55 条
  • [1] The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase
    Au, TK
    Collins, RA
    Lam, TL
    Ng, TB
    Fong, WP
    Wan, DCC
    [J]. FEBS LETTERS, 2000, 471 (2-3) : 169 - 172
  • [2] BATES RB, 2001, NMR DATA PURIFICATIO
  • [3] RETROVIRAL INTEGRATION - STRUCTURE OF THE INITIAL COVALENT PRODUCT AND ITS PRECURSOR, AND A ROLE FOR THE VIRAL IN PROTEIN
    BROWN, PO
    BOWERMAN, B
    VARMUS, HE
    BISHOP, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) : 2525 - 2529
  • [4] RETROVIRAL DNA INTEGRATION DIRECTED BY HIV INTEGRATION PROTEIN INVITRO
    BUSHMAN, FD
    FUJIWARA, T
    CRAIGIE, R
    [J]. SCIENCE, 1990, 249 (4976) : 1555 - 1558
  • [5] Tanshinone production in Ti-transformed Salvia miltiorrhiza cell suspension cultures
    Chen, H
    Yuan, JP
    Chen, F
    Zhang, YL
    Song, JY
    [J]. JOURNAL OF BIOTECHNOLOGY, 1997, 58 (03) : 147 - 156
  • [6] Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds
    Chen, JH
    Ho, CT
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1997, 45 (07) : 2374 - 2378
  • [7] In vitro assays for activities of retroviral integrase
    Chow, SA
    [J]. METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 12 (04): : 306 - 317
  • [8] MULTIPLE EFFECTS OF MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE ON VIRAL REPLICATION
    ENGELMAN, A
    ENGLUND, G
    ORENSTEIN, JM
    MARTIN, MA
    CRAIGIE, R
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (05) : 2729 - 2736
  • [9] Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)
    Esté, JA
    Cabrera, C
    Schols, D
    Cherepanov, P
    Gutierrez, A
    Witvrouw, M
    Pannecouque, C
    Debyser, Z
    Rando, RF
    Clotet, B
    Desmyter, J
    De Clercq, E
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (02) : 340 - 345
  • [10] GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523